The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Open accessAbstract
Nanotechnology offers several attractive design features that have prompted its exploration for cancer diagnosis and treatment. Nanosized drugs have a large loading capacity, the ability to protect the payload from degradation, a large surface on which to conjugate targeting ligands, and controlled or sustained release. Nanosized drugs also leak preferentially into tumor tissue through permeable tumor vessels and are then retained in the tumor bed due to reduced lymphatic drainage. This process is known as the enhanced permeability and retention (EPR) effect. However, while the EPR effect is widely held to improve delivery of nanodrugs to tumors, it in fact offers less than a 2-fold increase in nanodrug delivery compared with critical normal organs, resulting in drug concentrations that are not sufficient for curing most cancers. In this Review, we first overview various barriers for nanosized drug delivery with an emphasis on the capillary wall's resistance, the main obstacle to delivering drugs. Then, we discuss current regulatory issues facing nanomedicine. Finally, we discuss how to make the delivery of nanosized drugs to tumors more effective by building on the EPR effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Self-citationDrug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory
Vance, M. E., Kuiken, T., Vejerano, E. P., McGinnis, S. P., Hochella, M. F., Rejeski, D., & Hull, M. S. (2015) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.6.181 · Cited by 1,785
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Shrinkage necrosis: A distinct mode of cellular death
Kerr, J. F. R. (1971) · The Journal of Pathology · doi:10.1002/path.1711050103 · Cited by 1,454
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101
Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Mitsunaga, M., Ogawa, M., Kosaka, N., Rosenblum, L. T., Choyke, P. L., & Kobayashi, H. (2011) · Nature Medicine · doi:10.1038/nm.2554 · Cited by 1,057
Self-citationThe Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044
4 Histology and Histopathology
(2015) · Burghardt’s Colposcopy and Cervical Pathology · doi:10.1055/b-0035-108581 · Cited by 1,043
Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943
Dynamic interplay between the collagen scaffold and tumor evolution
Egeblad, M., Rasch, M. G., & Weaver, V. M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.015 · Cited by 896
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
Brown, E., McKee, T., diTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 836
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Maeda, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.038 · Cited by 814
Mechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
Lienard, D., Ewalenko, P., Delmotte, J. J., Renard, N., & Lejeune, F. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.52 · Cited by 719
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2000) · PubMed · Cited by 633
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Thurber, G. M., Schmidt, M. M., & Wittrup, K. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.012 · Cited by 624
Morphological Features of Cell Death
Ziegler, U., & Groscurth, P. (2004) · Physiology · doi:10.1152/nips.01519.2004 · Cited by 594
Sims, D. E. (1986) · Tissue and Cell · doi:10.1016/0040-8166(86)90026-1 · Cited by 586
Nanomedicines: addressing the scientific and regulatory gap
Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. (., Tamarkin, L., & Desai, N. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 546
Cancer nanomedicines: So many papers and so few drugs!
Venditto, V. J., & Szoka, F. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 537
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors
Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., & McDonald, D. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63540-7 · Cited by 528
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D., & Egorin, M. J. (2002) · PubMed · Cited by 505
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Matsumura, Y., & Kataoka, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01103.x · Cited by 501
Dromi, S., Frenkel, V., Luk, A., Traughber, B., Angstadt, M., Bur, M., Poff, J., Xie, J., Libutti, S. K., Li, K. C. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2443 · Cited by 492
Ultrasound mediated delivery of drugs and genes to solid tumors
Frenkel, V. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.007 · Cited by 474
FUKUMURA, D., DUDA, D. G., MUNN, L. L., & JAIN, R. K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00029.x · Cited by 451
Dickson, P. V., Hamner, J. B., Sims, T. L., Fraga, C. H., Ng, C. Y. C., Rajasekeran, S., Hagedorn, N. L., McCarville, M. B., Stewart, C. F., & Davidoff, A. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0278 · Cited by 441
Nano-sized MRI contrast agents with dendrimer cores
KOBAYASHI, H., & BRECHBIEL, M. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.016 · Cited by 437
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Monsky, W. L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H. A., Torchilin, V. P., Yuan, F., & Jain, R. K. (1999) · PubMed · Cited by 368
Increased nanoparticle penetration in collagenase-treated multicellular spheroids.
Goodman, T. T., Olive, P. L., & Pun, S. H. (2007) · PubMed Central · Cited by 362
Yurchenco, P. D., & Ruben, G. C. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.6.2559 · Cited by 358
Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.
Goel, S., Wong, A. H.-K., & Jain, R. K. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006486 · Cited by 352
Tumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 352
(1999) · PubMed · Cited by 348
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Maeda, H., Tsukigawa, K., & Fang, J. (2016) · Microcirculation · doi:10.1111/micc.12228 · Cited by 336
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
Wildiers, H., Guetens, G., De Boeck, G., Verbeken, E., Landuyt, B., Landuyt, W., de Bruijn, E. A., & van Oosterom, A. T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601005 · Cited by 334
Lipoprotein-Inspired Nanoparticles for Cancer Theranostics
Ng, K. K., Lovell, J. F., & Zheng, G. (2011) · Accounts of Chemical Research · doi:10.1021/ar200017e · Cited by 330
Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., Ancukiewicz, M., Boucher, Y., Jain, R. K., & Xu, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117610109 · Cited by 330
Cytochemical Methods for the Detection of Apoptosis
Willingham, M. C. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700901 · Cited by 309
Nanomedicine applied to translational oncology: A future perspective on cancer treatment
Bregoli, L., Movia, D., Gavigan-Imedio, J. D., Lysaght, J., Reynolds, J., & Prina-Mello, A. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.08.006 · Cited by 296
MAEDA, H. (2012) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.88.53 · Cited by 291
Design considerations for nanotherapeutics in oncology
Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 280
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
Ranjan, A., Jacobs, G. C., Woods, D. L., Negussie, A. H., Partanen, A., Yarmolenko, P. S., Gacchina, C. E., Sharma, K. V., Frenkel, V., Wood, B. J., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.011 · Cited by 267
Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of Tumors
Sano, K., Nakajima, T., Choyke, P. L., & Kobayashi, H. (2013) · ACS Nano · doi:10.1021/nn305011p · Cited by 263
Self-citationGrantab, R., Sivananthan, S., & Tannock, I. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3077 · Cited by 254
Driving delivery vehicles with ultrasound
Ferrara, K. W. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.002 · Cited by 250
Effect of tumour necrosis factor on cultured human melanoma cells
HELSON, L., GREEN, S., CARSWELL, E., & OLD, L. J. (1975) · Nature · doi:10.1038/258731a0 · Cited by 238
Kanapathipillai, M., Brock, A., & Ingber, D. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.005 · Cited by 234
The Diaphragms of Fenestrated Endothelia: Gatekeepers of Vascular Permeability and Blood Composition
Stan, R. V., Tse, D., Deharvengt, S. J., Smits, N. C., Xu, Y., Luciano, M. R., McGarry, C. L., Buitendijk, M., Nemani, K. V., Elgueta, R., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.11.003 · Cited by 232
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 230
Endothelial Gaps as Sites for Plasma Leakage in Inflammation
McDonald, D. M., Thurston, G., & Bałuk, P. (1999) · Microcirculation · doi:10.1111/j.1549-8719.1999.tb00084.x · Cited by 218
Molecular Mechanisms of Tumor Angiogenesis
Ziyad, S., & Iruela-Arispe, M. L. (2011) · Genes & Cancer · doi:10.1177/1947601911432334 · Cited by 215
Fraker, D. L., Alexander, H. R., Andrich, M., & Rosenberg, S. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.479 · Cited by 213
Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Drug-Loaded Nanocarriers: Passive Targeting and Crossing of Biological Barriers
M. Rabanel, J., Aoun, V., Elkin, I., Mokhtar, M., & Hildgen, P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800784702 · Cited by 205
Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application
Kobayashi, H., & Brechbiel, M. W. (2003) · Molecular Imaging · doi:10.1162/15353500200303100 · Cited by 202
Self-citationYasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 198
Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia
Li, L., ten Hagen, T. L. M., Bolkestein, M., Gasselhuber, A., Yatvin, J., van Rhoon, G. C., Eggermont, A. M. M., Haemmerich, D., & Koning, G. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.026 · Cited by 195
Dephosphorylation of Endothelial Nitric-oxide Synthase by Vascular Endothelial Growth Factor
Kou, R., Greif, D., & Michel, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204519200 · Cited by 192
Taghian, A. G., Abi-Raad, R., Assaad, S. I., Casty, A., Ancukiewicz, M., Yeh, E., Molokhia, P., Attia, K., Sullivan, T., Kuter, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.119 · Cited by 192
Ultrasound triggered, image guided, local drug delivery
Deckers, R., & Moonen, C. T. W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.117 · Cited by 190
Extravasation of polymeric nanomedicines across tumor vasculature
Danquah, M. K., Zhang, X. A., & Mahato, R. I. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.005 · Cited by 188
Nagamitsu, A., Greish, K., & Maeda, H. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp074 · Cited by 180
Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
Seki, T., Fang, J., & Maeda, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01323.x · Cited by 179
Photodynamic therapy: a means to enhanced drug delivery to tumors.
Snyder, J. W., Greco, W. R., Bellnier, D. A., Vaughan, L. A., & Henderson, B. W. (2003) · PubMed · Cited by 176
Chen, B., Pogue, B. W., Luna, J. M., Hardman, R. L., Hoopes, P. J., & Hasan, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1673 · Cited by 175
Yasuda, H., Yamaya, M., Nakayama, K., Sasaki, T., Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0436 · Cited by 170
Sonoporation enhances liposome accumulation and penetration in tumors with low EPR
Theek, B., Baues, M., Ojha, T., Möckel, D., Veettil, S. K., Steitz, J., van Bloois, L., Storm, G., Kiessling, F., & Lammers, T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.021 · Cited by 170
Hicks, K. O., Pruijn, F. B., Secomb, T. W., Hay, M. P., Hsu, R., Brown, J. M., Denny, W. A., Dewhirst, M. W., & Wilson, W. R. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj306 · Cited by 168
Biologically Optimized Nanosized Molecules and Particles: More than Just Size
Longmire, M. R., Ogawa, M., Choyke, P. L., & Kobayashi, H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200111p · Cited by 167
Self-citationPegylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer
Rose, P. G. (2005) · The Oncologist · doi:10.1634/theoncologist.10-3-205 · Cited by 158
Exploring the Tumor Microenvironment with Nanoparticles
Miao, L., & Huang, L. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_9 · Cited by 157
Magzoub, M. M., Jin, S., & Verkman, A. S. (2007) · The FASEB Journal · doi:10.1096/fj.07-9150com · Cited by 157
Mitsunaga, M., Nakajima, T., Sano, K., Choyke, P. L., & Kobayashi, H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200648m · Cited by 157
Self-citationMatrikines in the regulation of extracellular matrix degradation
Maquart, F., Bellon, G., Brassart‐Pasco, S., & Monboisse, J. C. (2004) · Biochimie · doi:10.1016/j.biochi.2004.10.006 · Cited by 157
FDA's Approach to Regulation of Products of Nanotechnology
Hamburg, M. A. (2012) · Science · doi:10.1126/science.1205441 · Cited by 152
Microvascular corrosion casting in the study of tumor vascularity: a review.
Konerding, M. A., Miodoński, A. J., & Lametschwandtner, A. (1995) · PubMed · Cited by 144
Nanomedicine : A Great First Year And, with Your Help, A Bright Future Ahead
Martin, C. R. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.265 · Cited by 130
Endothelial Gaps as Sites for Plasma Leakage in Inflammation
McDonald, D. M., Thurston, G., & Bałuk, P. (1999) · Microcirculation · doi:10.1080/713773924 · Cited by 129
Tumor Priming Enhances Delivery and Efficacy of Nanomedicines
Lü, D., Wientjes, M. G., Lu, Z., & Au, J. L. ‐. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121632 · Cited by 128
Ultrastructure of Basement Membranes
Inoué, S. (1989) · International review of cytology · doi:10.1016/s0074-7696(08)61334-0 · Cited by 127
Cancer nanomedicine: Addressing the dark side of the enhanced permeability and retention effect
Huynh, E., & Zheng, G. (2015) · Nanomedicine · doi:10.2217/nnm.15.86 · Cited by 125
Lammers, T., Peschke, P., Kühnlein, R., Subr, V., Ulbrich, K., Debus, J., Huber, P., Hennink, W., & Storm, G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.032 · Cited by 124
Chen, W., Tang, T. T.-L., Eastham-Anderson, J., Dunlap, D. Y., Alicke, B., Nannini, M., Gould, S. E., Yauch, R. L., Modrusan, Z. D., DuPree, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017945108 · Cited by 122
Sato, K., Watanabe, R., Hanaoka, H., Harada, T., Nakajima, T., Kim, I., Paik, C. H., Choyke, P. L., & Kobayashi, H. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.01.006 · Cited by 121
Self-citationKobayashi, H., & Choyke, P. L. (2015) · Nanoscale · doi:10.1039/c5nr05552k · Cited by 120
Self-citationGuided delivery of polymer therapeutics using plasmonic photothermal therapy
Gormley, A. J., Larson, N., Sadekar, S., Robinson, R., Ray, A., & Ghandehari, H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.04.002 · Cited by 119
Ho, Y.-J., Chang, Y., & Yeh, C. (2016) · Theranostics · doi:10.7150/thno.13727 · Cited by 112
DeNardo, S. J., Kukis, D. L., Kroger, L. A., OʼDonnell, R. T., Lamborn, K. R., Miers, L. A., DeNardo, D. G., Meares, C. F., & DeNardo, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4000 · Cited by 107
Yin, H., Fang, J. Q., Liao, L., Nakamura, H., & Maeda, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.018 · Cited by 105
Jang, S. H., Wientjes, M. G., & Au, J. L. ‐. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38848-2 · Cited by 100
Dealing with nanosafety around the globe—Regulation vs. innovation
Wacker, M. G., Proykova, A., & Santos, G. M. L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.015 · Cited by 100
Li, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96
Yokoi, K., Kojic, M., Milosevic, M., Tanei, T., Ferrari, M., & Ziemys, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3494 · Cited by 95
Marcucci, F., & Corti, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.007 · Cited by 94
Reichman, H. R., Farrell, C. L., & Maestro, R. F. D. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.65.2.0233 · Cited by 92
Potent and specific antitumor effect of CEA‐targeted photoimmunotherapy
Shirasu, N., Yamada, H., Shibaguchi, H., Kuroki, M., & Kuroki, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28907 · Cited by 92
McNerny, D. Q., Leroueil, P. R., & Baker, J. R. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.79 · Cited by 91
Fang, J. Q., Qin, H., Nakamura, H., Tsukigawa, K., Shin, T., & Maeda, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02178.x · Cited by 88
Kobayashi, H., Reijnders, K., English, S. J., Yordanov, A. T., Milenic, D. E., Sowers, A. L., Citrin, D. E., Krishna, M. C., Waldmann, T. A., Mitchell, J. B., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1175 · Cited by 85
Self-citationCancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates
Kobayashi, H., Türkbey, B., Watanabe, R., & Choyke, P. L. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500481x · Cited by 84
Self-citationKallikrein–kinin in infection and cancer
Maeda, H., Wu, J., Okamoto, T., Maruo, K., & Akaike, T. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00104-6 · Cited by 83
Botulinum toxin potentiates cancer radiotherapy and chemotherapy.
Ansiaux, R., Baudelet, C., Cron, G. O., Segers, J., Dessy, C., Martinive, P., Wever, J. D., Verrax, J., Wauthier, V., Beghein, N., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1222 · Cited by 82
Nakajima, T., Sano, K., Mitsunaga, M., Choyke, P. L., & Kobayashi, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1298 · Cited by 80
Self-citationCharacteristics of lymphatic endothelial cells in physiological and pathological conditions.
Ji, R. C. (2005) · PubMed · doi:10.14670/hh-20.155 · Cited by 77
Vlahovic, G., Rabbani, Z. N., Herndon, J. E., Dewhirst, M. W., & Vujaskovic, Z. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603366 · Cited by 77
The plasminogen activation system in inflammation
Rosso, M. D. (2008) · Frontiers in bioscience · doi:10.2741/3032 · Cited by 73
Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
Chan, R. C., Babbs, C. F., Vetter, R. J., et al. (1984) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/72.1.145 · Cited by 73
Eikenes, L., Tufto, I., Schnell, E. A., Bjørkøy, A., & Davies, C. D. L. (2010) · PubMed · Cited by 63
Tanaka, S., Akaike, T., Wu, J., Fang, J. Q., Sawa, T., Ogawa, M., Beppu, T., & Maeda, H. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086072 · Cited by 59
Turley, R. S., Fontanella, A. N., Padussis, J. C., Toshimitsu, H., Tokuhisa, Y., Cho, E. H., Hanna, G., Beasley, G. M., Augustine, C. K., Dewhirst, M. W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3000 · Cited by 59
Clarke, K., Lee, F.-T., Brechbiel, M. W., et al. (2000) · PubMed · Cited by 57
Ley, C. D., Horsman, M. R., & Kristjansen, P. E. G. (2007) · Neoplasia · doi:10.1593/neo.06733 · Cited by 57
Skliarenko, J., Lunt, S. J., Gordon, M. L., Vitkin, I. A., Milosevic, M., & Hill, R. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2046 · Cited by 51
Nano Delivers Big: Designing Molecular Missiles for Cancer Therapeutics
Patel, S., Bhirde, A. A., Rusling, J. F., Chen, X. S., Gutkind, J. S., & Patel, V. (2011) · Pharmaceutics · doi:10.3390/pharmaceutics3010034 · Cited by 49
Gil, M., Bieniasz, M., Seshadri, M., Fisher, D., Ciesielski, M. J., Chen, Y., Pandey, R. K., & Kozbor, D. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.429 · Cited by 47
Study of non-uniform nanoparticle liposome extravasation in tumour
Liu, P., Zhang, A., Xu, Y., & Xu, L. X. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500068643 · Cited by 39
Furuta, I., Yamada, H., Sagawa, T., et al. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000010222 · Cited by 35
Human pathological basis of blood vessels and stromal tissue for nanotechnology
Nishihara, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.005 · Cited by 35
Wang, K. K., Cottrell, W. J., Mitra, S., Oseroff, A. R., & Foster, T. H. (2009) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20847 · Cited by 33
Selective Transcatheter Arterial Embolization of Renal Carcinoma: An Original Technique
Turini, D., Nicita, G., Fiorelli, C., et al. (1976) · The Journal of Urology · doi:10.1016/s0022-5347(17)58840-0 · Cited by 31
Divan, A., Lawry, J., DUNSMORE, I. R., Parsons, M. A., & Royds, J. A. (2001) · PubMed · Cited by 22
Bradykinin relaxes contracted airways through prostaglandin production
Chand, N., & Eyre, P. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11349.x · Cited by 16
Ivanković, S. (2009) · Oncology Reports · doi:10.3892/or_00000562 · Cited by 8
Pharmakoangiographie bei Lebertumoren
Georgi, M., & Freitag, B. (1980) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-2008-1056566 · Cited by 5
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
Monro, S., Colón, K. L., Yin, H., Roque, J., Konda, P., Gujar, S., Thummel, R. P., Lilge, L., Cameron, C. G., & McFarland, S. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,461
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Metadata
- Authors
- Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-09-02
- Volume
- 27
- Issue
- 10
- Pages
- 2225-2238
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2518509288
- Cited by
- 1,101
- References
- 159
- FWCI
- 29.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.